Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutra PharmaNPHC EV-to-OCF is -12.44 as of Sep. 17, 2026. The stock has 5 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Nutra Pharma ranks better than 83.42% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Nutra Pharma's Enterprise Value is $13.06 Mil.
Nutra Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.05 Mil. Therefore, Nutra Pharma's EV-to-OCF for today is -12.44.
The historical rank and industry rank for Nutra Pharma's EV-to-OCF or its related term are showing as below:
NPHC'
s EV-to-OCF Range Over the Past 10 Years
Min: -12.44 Med: -2.14 Max: -2.06
Current: -12.44
During the past 13 years, the highest EV-to-OCF of Nutra Pharma was -2.06. The lowest was -12.44. And the median was -2.14.
NPHC's EV-to-OCF is ranked better than 83.42% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 10.15
vs NPHC: -12.44
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nutra Pharma's PE Ratio (TTM) for today is calculated as:
Nutra Pharma's share price for today is $0.0001.
Nutra Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nutra Pharma EV-to-OCF Related Terms
Nutra Pharma EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Nutra Pharma's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nutra Pharma's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutra Pharma EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nutra Pharma's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Nutra Pharma's EV-to-OCF falls into.
Nutra Pharma's current Enterprise Value is $13.06 Mil.
Nutra Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutra Pharma (NPHC) has a EV-to-OCF of -12.44 as of Sep. 17, 2026. According to the industry distribution chart, Nutra Pharma ranks #167 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 16.6%.
Is Nutra Pharma's EV-to-OCF too high?
Nutra Pharma's current EV-to-OCF is -12.44. Based on the distribution chart, Nutra Pharma ranks #167 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Nutra Pharma's EV-to-OCF compare to CBDY and SKYI?
According to the Drug Manufacturers industry distribution chart, Nutra Pharma ranks #167 out of 1007 companies for EV-to-OCF. This places Nutra Pharma in the top 17% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 10.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.15, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutra Pharma's current EV-to-OCF is -12.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutra Pharma stock overvalued right now?
Nutra Pharma (NPHC) has a current EV-to-OCF of -12.44. The current EV-to-OCF is -12.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Nutra Pharma (NPHC), the current EV-to-OCF is -12.44 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nutra Pharma Corp operates as a biopharmaceutical company with intellectual property for drugs that treat autoimmune disorders, viral diseases, and pain. It is focused on homeopathic and drug discovery research and clinical development, and has developed four homeopathic drugs for the relief of pain: Nyloxin and Nyloxin Extra Strength, Pet Pain-Away, Equine Pain-Away, and Luxury Feet. Additionally, the company has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases; and RPI-MN, to treat viral diseases, including HIV/AIDS and Herpes. Nutra Pharma produces, markets, and distributes its branded products both domestically and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NPHC has been successfully added to your 
